Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Use Disorder
NCT05266716
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
79
Enrollment
INDUSTRY
Sponsor class
Conditions
Methamphetamine Abuse
Interventions
BEHAVIORAL:
Affect Methamphetamine Treatment Program
Sponsor
Affect Therapeutics, Inc.